Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Authors
Santoro, ATursz, T
Mouridsen, H
Verweij, Jaap
Steward, William P
Somers, R
Buesa, J
Casali, P
Spooner, D
Rankin, Elaine M
Affiliation
Divisione Oncologia Medica A, Istituto Nazionale Tumori, Milano, Italy.Issue Date
1995-07